Biotricity (NASDAQ:BTCY) Downgraded to “Neutral” at HC Wainwright

HC Wainwright cut shares of Biotricity (NASDAQ:BTCY) from a buy rating to a neutral rating in a research note released on Monday, Marketbeat reports.

Biotricity Price Performance

Shares of BTCY opened at $0.95 on Monday. The stock has a market capitalization of $8.14 million, a price-to-earnings ratio of -0.60 and a beta of 2.34. Biotricity has a 12-month low of $0.70 and a 12-month high of $7.56. The company’s fifty day moving average is $1.72.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.